Log in or Sign up for Free to view tailored content for your specialty!
Vaccination News
New Jersey, Delaware announce end dates for school mask mandates
The governors of New Jersey and Delaware announced Monday that COVID-19 mask mandates for K-12 schools will end next month, joining other states that have already lifted such measures.
Gay and lesbian adults report high COVID-19 vaccine coverage
Gay and lesbian adults in the United States reported higher levels of COVID-19 vaccination and vaccine confidence than heterosexual adults, according to a new study published in MMWR.
Log in or Sign up for Free to view tailored content for your specialty!
Caregivers of childhood cancer survivors express hesitancy on COVID vaccination
Many caregivers expressed hesitancy to vaccinate themselves and their children who had cancer against COVID-19, according to study results published in Pediatric Blood & Cancer.
Studies offer ‘reassuring’ data on COVID-19 vaccination, menstruation
Two recent studies have found small but reversible changes in menstruation following COVID-19 vaccination, according to a review of recent data published in the BMJ.
Physicians struggle against omicron surge, confusing guidelines and limited resources
The new year rung in record highs of COVID-19 cases as omicron quickly surpassed delta as the dominant variant in the U.S., according to the CDC.
Hospitalization rate 23 times higher for unvaccinated vs. boosted during omicron
Data from Los Angeles County during the omicron surge showed that the COVID-19 hospitalization rate was 23 times higher among people who were unvaccinated compared with people who had received a COVID-19 vaccine series and booster.
NIH trial will test reducing medication to boost vaccine response in transplant recipients
A phase 2 trial will evaluate if temporarily reducing the immunosuppressive medication of transplant recipients in the days before and after they receive an additional dose of COVID-19 vaccine increases their immune response to the vaccine.
Pfizer, BioNTech begin application for COVID-19 vaccine for children under 5
Pfizer and BioNTech are expected to ask the FDA to authorize a two-dose regimen of their COVID-19 vaccine for emergency use in children younger than age 5 years, according to multiple reports.
Top in ID: Long COVID risk factors, new trial for omicron-specific vaccine
A new study identified four factors that may heighten the risk for long COVID, a condition estimated to affect 31% to 69% of patients with COVID-19. It was the top story in infectious disease last week.
Novavax asks FDA to authorize its protein-based COVID-19 vaccine
Novavax on Monday announced that it has submitted an emergency use authorization request to the FDA for its protein-based COVID-19 vaccine for individuals aged 18 years or older.
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read